These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30613831)

  • 21. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
    Liu D; Li B; Bi C; Qiao H; Wu X
    Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment.
    Altai M; Wållberg H; Honarvar H; Strand J; Orlova A; Varasteh Z; Sandström M; Löfblom J; Larsson E; Strand SE; Lubberink M; Ståhl S; Tolmachev V
    J Nucl Med; 2014 Nov; 55(11):1842-8. PubMed ID: 25278516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rod-shaped polypeptide nanoparticles for siRNA delivery.
    Li D; Li X; Bai J; Liu Y; de Vries R; Li Y
    Int J Biol Macromol; 2021 Jan; 166():401-408. PubMed ID: 33122069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modularized peptides modified HBc virus-like particles for encapsulation and tumor-targeted delivery of doxorubicin.
    Shan W; Zhang D; Wu Y; Lv X; Hu B; Zhou X; Ye S; Bi S; Ren L; Zhang X
    Nanomedicine; 2018 Apr; 14(3):725-734. PubMed ID: 29275067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.
    McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M
    Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core.
    Rybka JD; Mieloch AA; Plis A; Pyrski M; Pniewski T; Giersig M
    Nanomaterials (Basel); 2019 Jan; 9(2):. PubMed ID: 30691173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.
    Liu Y; Song Z; Zheng N; Nagasaka K; Yin L; Cheng J
    Nanoscale; 2018 Aug; 10(32):15339-15349. PubMed ID: 30070662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Near-Infrared Light-Triggered Polyprodrug/siRNA Loaded Upconversion Nanoparticles for Multi-Modality Imaging and Synergistic Cancer Therapy.
    Kuang G; Lu H; He S; Xiong H; Yu J; Zhang Q; Huang Y
    Adv Healthc Mater; 2021 Oct; 10(20):e2100938. PubMed ID: 34218522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Stable Indocyanine Green (ICG)-Mediated Cancer Optotheranostics with Naturalized Hepatitis B Core Particles.
    Shan W; Chen R; Zhang Q; Zhao J; Chen B; Zhou X; Ye S; Bi S; Nie L; Ren L
    Adv Mater; 2018 Jul; 30(28):e1707567. PubMed ID: 29786899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.
    Kazaks A; Lachmann S; Koletzki D; Petrovskis I; Dislers A; Ose V; Skrastina D; Gelderblom HR; Lundkvist A; Meisel H; Borisova G; Krüger DH; Pumpens P; Ulrich R
    Intervirology; 2002; 45(4-6):340-9. PubMed ID: 12602354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of Cationic Multiwalled Carbon Nanotubes as Efficient siRNA Vectors for Lung Cancer Xenograft Eradication.
    Guo C; Al-Jamal WT; Toma FM; Bianco A; Prato M; Al-Jamal KT; Kostarelos K
    Bioconjug Chem; 2015 Jul; 26(7):1370-9. PubMed ID: 26036843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment.
    Bulbake U; Kommineni N; Ionov M; Bryszewska M; Khan W
    Pharm Dev Technol; 2020 Jan; 25(1):9-19. PubMed ID: 30633621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein.
    Orlova A; Jonsson A; Rosik D; Lundqvist H; Lindborg M; Abrahmsen L; Ekblad C; Frejd FY; Tolmachev V
    J Nucl Med; 2013 Jun; 54(6):961-8. PubMed ID: 23528382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear export and import of human hepatitis B virus capsid protein and particles.
    Li HC; Huang EY; Su PY; Wu SY; Yang CC; Lin YS; Chang WC; Shih C
    PLoS Pathog; 2010 Oct; 6(10):e1001162. PubMed ID: 21060813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation.
    Ludgate L; Liu K; Luckenbaugh L; Streck N; Eng S; Voitenleitner C; Delaney WE; Hu J
    J Virol; 2016 Jun; 90(12):5830-5844. PubMed ID: 27076641
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Nishimura Y; Ezawa R; Morita K; Nakayama M; Ishii J; Sasaki R; Ogino C; Kondo A
    ACS Appl Bio Mater; 2020 Nov; 3(11):7743-7751. PubMed ID: 35019514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer.
    Kotcherlakota R; Srinivasan DJ; Mukherjee S; Haroon MM; Dar GH; Venkatraman U; Patra CR; Gopal V
    J Mater Chem B; 2017 Sep; 5(34):7082-7098. PubMed ID: 32263899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein.
    Chu TH; Liou AT; Su PY; Wu HN; Shih C
    J Virol; 2014 Mar; 88(5):2530-43. PubMed ID: 24352445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
    Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
    Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel hydroxybutyl chitosan nanoparticles for siRNA delivery targeting tissue factor inhibits proliferation and induces apoptosis in human vascular smooth muscle cells.
    Wan K; Li J; Li D; Ge J; Wang Y; Li X; Guo Y; Guo J; Leng M; Wang P; An Y
    Mol Med Rep; 2015 Dec; 12(6):7957-62. PubMed ID: 26497351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.